$NXXT

NEXTNRG, INC. (NXXT): Results of Operations and Financial Condition

NEXTNRG, INC. (NXXT) filed an SEC Form 8-K — Results of Operations and Financial Condition. false 0001817004 0001817004 2026-08-13 2026-08-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C., 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Repo

Original reporting
Published Aug 13, 2026, 8:36 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 8:40 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$NXXT
Neutral
low confidence
Mentioned
$NXXT
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$NXXTNeutralLow
01

Why it matters

The excerpt confirms the company released quarterly results for the quarter ended June 30, 2026, but provides no figures or guidance, limiting immediate trading inference.

02

Market read

Traders should treat this as an earnings-results disclosure event, but the excerpt lacks the specific financial datapoints needed to judge impact.

03

What to watch

Check Exhibit 99.1 for revenue, margins, cash burn, liquidity, and any forward-looking statements, which are typically what drive trading after an 8-K results release.

Relevance 7/10Novelty 3/10Timing: Filed Aug 13, 2026, after-hours/late session with Exhibit 99.1 results for quarter ended June 30, 2026.

Background

The filing is an SEC Form 8-K, Item 2.02, used to report quarterly financial results via a furnished press release (Exhibit 99.1).

Company-level read

Ticker impact

$NXXTNeutralLow confidence
Context

NextNRG filed an 8-K stating it issued a press release with financial results for the quarter ended June 30, 2026.

Expected impact

Near-term volatility possible on the actual results, but direction cannot be inferred from the provided excerpt.

Evidence & confidence

The 8-K confirms results were released and attached as Exhibit 99.1, yet the excerpt contains no numbers, outlook, or qualitative drivers.

Market effects

No sector read-through is provided in the excerpt beyond a routine quarterly results filing.

None indicated.

None indicated.

Counterpoint

Because the excerpt omits the actual results, traders may overreact to the filing itself; the real catalyst is the content of Exhibit 99.1.

Key entities

  • NEXTNRG, Inc.

    Subject of the 8-K filing, reporting quarterly results for the quarter ended June 30, 2026 via Exhibit 99.1.

  • Michael Farkas

    CEO signing the 8-K.

Related articles

$CPKMedAI 8/10

Chesapeake Utilities (CPK) Q2 2026 Earnings Call Transcript

Chesapeake Utilities (CPK) reported Q2 2026 adjusted net income of $25.4 million, up 5% year over year, and adjusted EPS of $1.05. Management raised 2026 capital guidance to $550 million to $600 million and expects 2028 EPS of $7.75 to $8.00. It also discussed the $1.2 billion Florida Energy Pathway project and reaffirmed efficiency and dividend plans.

$QNSTHighAI 9/10

QuinStreet (QNST) Q4 2026 Earnings Call Transcript

QuinStreet (QNST) reported Q4 FY2026 revenue of $373.9M, up 43% y/y, and full-year revenue of $1.3B, up 18% y/y, driven by Financial Services and Home Services. Adjusted EBITDA rose to $41.4M (11.1% margin). Non-GAAP EPS was $0.50 in Q4. Q1 2027 revenue guidance is $370M-$380M.

$AVPTMedAI 9/10

AvePoint (AVPT) Q2 2026 Earnings Call Transcript

AvePoint (AVPT) reported Q2 2026 revenue of $124.5M, up 22% YoY, with SaaS revenue $98.5M (79% of total). Total ARR was $465.1M (+27%), net new ARR $29.9M, and GAAP operating margin 8.2%. Full-year guidance: ARR $522.1M-$528.1M and revenue $508.5M-$512.5M. The company also spent $50M on share repurchases in Q2.

$NUTXMedAI 8/10

Nutex Health (NUTX) Q2 2026 Earnings Call Transcript

Nutex Health (NUTX) reported Q2 2026 results on an earnings call. Total revenue fell to $210.8M from $244.0M. Net income rose to $65.8M, diluted EPS to $9.38, and adjusted EBITDA to $90.0M. Management cited lower contract services costs from a HaloMD amendment and higher patient visits, plus a hospital expansion pipeline.

$ALRMMedAI 9/10

Alarm.com (ALRM) Q2 2026 Earnings Call Transcript

Alarm.com (ALRM) reported Q2 2026 results. SaaS and license revenue was $188.8 million, up 11.1% YoY and above guidance midpoint. Total revenue rose 9.2% to $277.7 million. Non-GAAP adjusted EBITDA was $57.7 million, up 15.7%, and adjusted EPS was $0.77. Full-year guidance was raised for SaaS, total revenue, and adjusted EBITDA.

$INTCMedAI 8/10

A $20 Billion Reason Why Intel Stock Is in Focus

Intel expects Q3 revenue of $15.8B to $16.8B versus about $15.1B consensus, and adjusted EPS of $0.38 versus $0.27 consensus. Intel raised 2026 capital spending to over $20B and plans more in 2027. It is investing in Ireland foundry operations and signed 10 server CPU customer agreements. Analysts are mixed on INTC targets.